All News

Use of Live-Donor Liver Transplants in Patients With Metastatic Colon Cancer Leads to ‘Excellent Survival’

March 31st 2022

Patients with colorectal cancer that has spread to the liver tend to have poor outcomes and are typically not candidates to receive liver transplants from deceased donors. However, results from a small study on transplanting livers from live-donors could "change this paradigm," an expert said.

My 'Emotional Anchor' Through This COVID-19 Pandemic Has Been a Virtual Group of Fellow Cancer Survivors

March 31st 2022

Twice a week, my local Gilda’s Club holds a “Lunch and Laughs” group meeting with cancer survivors that has kept me grounded through COVID-19 isolation and beyond.

'Give Yourself Grace’ Amidst the Potential Fear of Cancer Recurrence During Survivorship

March 31st 2022

As a patient moves from treatment to survivorship, the fear of cancer recurrence may overshadow the ability for them to recognize how much they have endured, but support is available to hopefully lessen the burden.

Educated Patient® Multiple Myeloma Summit Risk Stratification for the Newly Diagnosed Presentation: March 12, 2022

March 31st 2022

Watch Dr. Carlyn Rose Tan, an assistant attending in myeloma service at Memorial Sloan Kettering Cancer Center, present on risk stratification for newly diagnosed patients.

Novel Therapy-Tecentriq Combo Fails to Improve Survival in an Aggressive Form of Lung Cancer

March 30th 2022

Tiragolumab plus Tecentriq and chemotherapy did not significantly improve progression-free survival and overall survival in patients with extensive-stage small-cell lung cancer.

Universal Genetic Testing Should be Recommended for All Patients With Colon Cancer, Says Expert

March 30th 2022

Performing genetic testing in every patient diagnosed with colon cancer, and not just those considered high-risk, could identify that person's risk of developing another cancer later in life.

Cancer Treatment Decisions May Lead to Costly Risks, But You Can't Dwell on the 'What-If's'

March 30th 2022

My daughter’s radiation oncologist said that certain treatments may lead to another cancer diagnosis later in her life, but isn’t living better now worth the risk?

Early-Stage Clinical Trial Treats First Patient With Life-Threatening Cancer Metastases With Investigational Drug

March 30th 2022

It is expected that up to 18 patients with leptomeningeal metastases — a serious form of cancer that has spread from its original location to an area surrounding the brain and spinal cord — will receive treatment with the investigational drug.

Educated Patient® Multiple Myeloma Summit MGUS/Smoldering Myeloma Presentation: March 12, 2022

March 30th 2022

Watch Dr. Neha S. Korde, an assistant professor in multiple myeloma service in the Division of Hematology at Memorial Sloan Kettering Cancer Center, present on MGUS/smoldering myeloma.

First Patient Enrolled Onto Study Evaluating Zepzelca Monotherapy for Treatment of Certain Solid Tumors

March 29th 2022

Approximately 60 patients with metastatic/unresectable solid tumors, including bladder cancer, are expected to be enrolled onto a clinical trial assessing the safety and efficacy of Zepzelca.

FDA’s Keytruda Approval for Subset of Advanced Endometrial Cancer Provides Patients With a ‘Practice Changing’ Treatment Option

March 29th 2022

Keytruda was well tolerated and demonstrated practice-changing responses with potential for a curative approach in a group of patients with advanced endometrial cancer, according to an expert.

Surviving Cancer Is ‘Agonizingly Slow'

March 29th 2022

Spring has arrived, and along with it has come fresh challenges and new perspectives regarding my cancer survivorship.

The Changing Landscape of Colorectal Cancer Treatment Opens the Door to More Precise Techniques, Higher Survivorship Rates

March 29th 2022

Twenty years of updates in technology, techniques and available medications has provided more hope for patients with colorectal cancer, with more advances on the horizon.

Support Groups Are ‘So Good’ For Survivors Who Don’t Want to Burden Family With Fear of Cancer Recurrence

March 29th 2022

Cancer survivors may often struggle with talking about their fear of recurrence with loved ones, which is why one expert recommends they seek solace in support groups.

Clinical Trial Investigating a Combo Therapy in Brain Cancer Now Enrolling Patients

March 28th 2022

The study authors plan to enroll 24 patients with glioblastoma, an aggressive brain tumor, to assess the efficacy an investigational drug plus Libtayo prior to surgery to remove the tumor.

‘Authentically Empathic’ Late-Stage Patient Inspires Fellow Cancer Survivor

March 28th 2022

When lovers of “Pinky and the Brain,” “Teenage Mutant Ninja Turtles” and other cartoons gathered in voice actor Rob Paulsen’s hospital room, he took particular notice of one exuberant woman with cancer who was extroverted and kind, despite not having long to live.

The Hunt for Perfect Post-Mastectomy Boobs Continues

March 28th 2022

Since having both breasts removed in 2014, I’ve been on a hunt for the perfect replacements. Through trial and error, I’ve gone through the good, the bad and the ugly, but finally came across a product that seemed to meet my needs.

FDA’s Approval of Pluvicto Gives Some Patients With Prostate Cancer a ‘Truly Targeted Therapy’ With Modest Side Effects

March 28th 2022

A recently FDA-approved drug offers patients with metastatic castration-resistant prostate cancer a newer treatment that improves survival, but is not curative of the disease, which means that more research is needed, according to an expert.

Increased Use of First-Line Maintenance Treatment Is ‘Reassuring’ for Patients With Ovarian Cancer

March 28th 2022

It is essential that patients and providers discuss appropriate options for maintenance therapy after ovarian cancer, one expert explained.

FDA Rejects Request to Approve Novel Drug Combination in NSCLC

March 27th 2022

The FDA’s decision follows a recommendation from a panel of experts that suggested the agency not approve sintilimab plus the chemotherapy pemetrexed and platinum-based chemotherapy for patients with non-squamous non-small cell lung cancer.

Birthday Reflections on My Cancer Experience: I’m Fighting the Best I Can

March 26th 2022

Today is my birthday, and while I’ve had some unforeseen changes in my cancer treatment lately, I’m grateful to still be here to celebrate.

Imfinzi Fails to Improve Survival in Locally Advanced Cervical Cancer

March 25th 2022

AstraZeneca, the manufacturer of the drug, announced that treatment with Imfinzi plus chemoradiotherapy did not improve survival compared with standard-of-care chemoradiotherapy alone in patients with locally advanced cervical cancer.

First Patient Dosed in Early-Phase Trial Investigating a New Drug for Bladder Cancer

March 25th 2022

The trial will be testing TARA-002 in patients with non-muscle invasive bladder cancer with high-grade carcinoma in situ and high-grade papillary tumors.

Cancer Conferences Helped Me Grow as an Advocate

March 25th 2022

At first, I struggled to keep up with the scientific jargon being presented at a cancer conference, but eventually I hit my stride and now I leave these events with a renewed sense of inspiration.

‘Today Show’ Anchor Hoda Kotb Discusses Fertility Issues Following Cancer Diagnosis, Pfizer Pulls Blood Pressure Drugs Due to Cancer Concerns and More

March 25th 2022

From Pfizer issuing a voluntary recall of three blood pressure drugs due to a high level of a cancer-causing chemical to “Today Show” co-ancho Hoda Kotb discussing her struggles with fertility after receiving a diagnosis of breast cancer, here’s what’s happening in the cancer space this week.

Let It Go: A Popular Disney Song Taught Me How to Live After Cancer

March 25th 2022

I let go of knowing I won’t ever be without anxiety of my cancer growing again and let go of the idea of any “old me” returning. I was now focusing on the “new me.”

Novel Drug-Keytruda Combo Meets Goal for Kidney Cancer Outcomes Before Trial Enrollment Ends

March 24th 2022

MRX0518 plus Keytruda led to a clinical benefit in four out of 16 evaluable patients with renal cell carcinoma. The drug duo will continue to be studied for multiple types of solid tumors.

Triple-Class Refractory Myeloma Requires ‘Greater Attention to Symptoms'

March 24th 2022

To address symptoms from myeloma that is resistant to treatment, education and communication with care teams are key.

As Spring Breakers Break COVID-19 Precautions, I Found Inspiration in One Steadfast Young Man

March 24th 2022

Many young adults seem to be throwing caution to the wind with COVID-19 precautions, but a neighbor of mine gave me hope for the younger generations since he was steadfast in protecting vulnerable people like me.

Potential FDA Cancer Drug Approvals on the Horizon This Spring

March 24th 2022

The Food and Drug Administration plans on reviewing multiple new cancer therapies this spring.